Cytokinetics (CYTK) Q2 2023 Earnings

4MayConfirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
-1.52
-1.09
-0.66
-0.23

Details

Expected EPS
-1.19
Actual EPS
-1.38
Surprise EPS
-0.19
Surprise Percent
+15.97%

Description

Cytokinetics (CYTK) has reported earnings of -1.38 per share for Q2 2023.

0 Comments

Share your thoughts